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Summary
Hypertension, a risk factor for many cardiovascular, cer-
ebrovascular, and renal diseases, affects one in four
Americans, at an annual cost of 1$30 billion. Although
genetic mutations have been identified in rare forms of
hypertension, including Liddle syndrome and glucocor-
ticoid-remediable aldosteronism, the abundance of plau-
sible candidate genes and potential environmental risk
factors has complicated the genetic dissection of more
prevalent essential hypertension. To search systemati-
cally for chromosomal regions containing genes that reg-
ulate blood pressure, we scanned the entire autosomal
genome by using 367 polymorphic markers. Our study
population, selected from a blood-pressure screen of
1200,000 Chinese adults, comprises rare but highly ef-
ficient extreme sib pairs (207 discordant, 258 high con-
cordant, and 99 low concordant) and all but a single
parent of these sibs. By virtue of the sampling design,
the number of sib pairs, and the availability of genotyped
parents, this study represents one of the most powerful
of its kind. Although no regions achieved a 5% ge-
nomewide significance level, maximum LOD-score val-
ues were 12.0 (unadjusted ) for regions con-P ! .001
taining five markers (D3S2387, D11S2019, D15S657,
D16S3396, and D17S1303), in our primary analysis.
Other promising regions identified through second-
ary analyses include loci near D4S3248, D7S2195,
D10S1423, D20S470, D20S482, D21S2052, PAH, and
AGT.
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Introduction
The possibility of mapping quantitative-trait loci (QTL)
by using sib pairs with extreme phenotypes (hereafter
referred to as “extreme sib pairs”) has recently generated
much attention (Risch and Zhang 1995). This sampling
design is widely recognized as being substantially more
powerful than a design that uses randomly ascertained
sibs (Carey and Williamson 1991; Cardon and Fulker
1994; Risch and Zhang 1995). However, the efficiency
of extreme sib pairs is counterbalanced by the large
screening effort needed to identify them (Risch and
Zhang 1996). Through an international collaboration
with researchers in Anqing, China, we have performed
such a screen and have completed an initial genome scan
in search of genes regulating blood pressure (BP).
In many ways, Anqing is an ideal setting for collection
of extreme sib pairs and for the study of BP. First, its
population of ∼6 million is sufficiently large to contain
an adequate number of extreme sib pairs. Second, the
combination of a well-established three-tier medical sys-
tem (county, township, and village) and our extensive
research network in China allow us to systematically
ascertain these sib pairs. Third, although large, this pre-
dominantly rural population is relatively homogeneous.
For example, diets and lifestyles tend to be more uniform
than those in countries such as the United States. More-
over, genetic diversity has been limited by the rugged
terrain and lack of public and private vehicles. Fourth,
stable family units allow parental DNA to be collected
in many cases. Fifth, BP medication in this part of China
is rare, so that the natural variation of BP can more
readily be observed.
To attain our extreme sib pairs, we screened 1200,000
adults from Anqing. Initially, we identified all study sub-
jects having extreme systolic BP (SBP) or extreme dia-
stolic BP (DBP). To qualify as extreme, a measurement
must be in the top or bottom age-specific decile defined
on the basis of the first ∼40,000 participants (table 1).
From this population, we identified extreme discordant
sib pairs (EDSPs), high concordant sib pairs (HCSPs),
and low concordant sib pairs (LCSPs) and chose those
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Table 1
BP Distribution in Anqing Counties of Huaining and Zongyang
CATEGORY AND AGE (NO. OF SUBJECTS)
BP, AT PERCENTILE
(mmHg)
MEAN BP (SD)5% 8% 10% 25% 50% 75% 90% 92% 95%
SBP:
15–34 (18,918) 92 96 98 106 114 122 130 132 138 114.8 (13.9)
35–39 (2,246) 92 96 98 106 116 126 136 138 142 117.6 (16.2)
40–44 (4,161) 96 98 100 108 118 128 138 140 148 120.2 (16.9)
45–49 (3,897) 96 98 100 110 120 130 144 148 156 123.1 (18.8)
50–55 (12,154) 100 104 106 118 130 146 166 170 180 134.1 (25.3)
DBP:
15–34 (18,892) 50 54 56 60 68 76 82 84 86 69.1 (11.2)
35–39 (2,242) 52 56 58 62 70 78 84 86 90 71.3 (11.9)
40–44 (4,159) 54 56 58 64 72 78 88 90 92 72.7 (12.1)
45–49 (3,894) 56 58 60 66 74 80 88 90 94 73.7 (12.4)
50–55 (12,131) 56 58 60 68 76 84 92 96 100 76.1 (14.1)
with available parental DNA (table 2) for inclusion in
a genomewide scan for linkage based on 367 autosomal
markers and multipoint linkage analysis. In this article,
we present the results of our scan and discuss strategies
to further investigate several promising regions.
Subjects and Methods
DNA samples and related data were collected in Anq-
ing through the Harvard-Anhui Collaborative Project on
Environment, Nutrition, Genetics, and Cardiovascular/
Respiratory Diseases, a large-scale epidemiological pro-
ject initiated in 1993 by scientists from Harvard School
of Public Health, Harvard Medical School, Anhui Med-
ical University (AMU), and the Anqing Health Bureau.
Study Site
Spanning 80 km along the north bank of the Yangtze
River, Anqing has one major urban area and eight rural
counties covering 15,000 km2. The climate is mild, with
average year-round temperatures of ∼15C. Available re-
cords indicate settlement 2,000 years ago, and popula-
tion stability is reflected by strictly regional Anqing di-
alects. Because divorce and migration are uncommon in
Anqing, and because China’s single-child policy is not
widely enforced, families tend to be large and stable.
BP Distributions and Eligibility Requirements
A community-based survey was conducted on
1200,000 residents of Anqing, to collect information on
BP, height, and weight. Age-adjusted BP distributions for
decile determination were estimated (with 1-mm-Hg
precision) on the basis of a pilot study comprising the
first ∼40,000 participants (table 1). These distributions,
as well as those from the entire screen (completed in
April 1996) were comparable to the distributions from
an independent survey conducted in 1993 on 120,000
adults from the same area (Xu et al. 1997). To be eligible
for the final phase of our study (i.e., genomic screening),
an individual had to meet the following criteria: (1) a
resting SBP or DBP (average of three readings) in the
top or bottom age-adjusted decile, at each of the three
screening stages described below; (2) age 15–55 years;
(3) the existence of at least one sib in the same age group
who also satisfied criterion (1); and (4) availability of
DNA from both parents. Informed consent was obtained
from all participants, and the study was approved by
the Human Subjects Committee at the Harvard School
of Public Health.
Family Ascertainment
A three-stage procedure (done on three separate days)
was used to determine which families met the eligibility
criteria. First, after receiving rigorous study-specific
training and then passing the required proficiency tests,
village doctors conducted an initial screening survey. Sec-
ond, a field team, which included an epidemiologist from
the Anhui Meizhong Institute for Biomedical Science and
Environmental Health and a group of experienced AMU
faculty members, was sent to the villages to confirm BP
measurements on families initially found to be eligible.
Finally, after positive confirmation, a formal study was
conducted at a central office located in the area hospital.
Previously validated questionnaires were administered
by specially trained interviewers, to gather epidemiolog-
ical, demographic, and dietary information (Chinese
Academy of Preventive Medicine 1990). Anthropomor-
phic measurements, including height and weight, were
taken by trained and certified examiners following stan-
dard protocols. BP measurements were obtained after
subjects had rested for 10 min. Measurements were
made with the patient in the seated position, by nurses
using mercury-gravity manometers and appropriately
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Table 2
Clinical Characteristics of Study Subjects Used for Genomic Screening
PARENTS
OFFSPRING
1st Decile,
SBP or DBP
10th Decile,
SBP or DBP
No. 673 269 508
Male/female 50%/50% 42%/58% 69%/31%
Mean age (SD) 58.9 years (7.6 years) 28.9 (6.1 years) 30.5 (6.6 years)
Proportion taking antihypertensive medication 6% 0% 2%
Mean body-mass index (SD) 21.8 kg/m2 (6.8 kg/m2) 20.9 kg/m2 (2.5 kg/m2) 22.8 kg/m2 (3.1 kg/m2)
sized cuffs. Triplicate measurements on the same arm
were taken, with an interval of 30 s between readings.
Each patient’s SBP and DBP were then calculated as the
mean of the three independent measurements. All pro-
tocols are fully compatible with standardized methods
used in the United States.
Phlebotomy
Fore-arm venous-blood samples were obtained from
all study participants via venipuncture. Samples were
collected in 10-ml Vacutainer tubes (Becton Dickinson)
containing either EDTA (two tubes) or citrate (two
tubes). Tubes were kept on ice and subsequently were
centrifuged for 10 min in a tabletop refrigerated centri-
fuge at 4,000 g. Plasma was subsequently removed from
the cell pellet by pipetting. All samples were frozen and
stored at 85C.
DNA Extraction
DNA extraction was done at the Anhui Meizhong
Institute for Biomedical Science and Environmental
Health. Isolation of genomic DNA was performed by
means of Puragene DNA Isolation Kits (Gentra Sys-
tems), by a modification of methods described elsewhere
(Buffone and Darlington 1985). This DNA-extraction
protocol typically yields 300 mg of DNA from 10 ml of
whole blood with an . After extrac-OD /OD ≈ 1.8260 280
tion, half of the DNA sample was sent to the Program
for Population Genetics, for genetic analysis, and the
other half was stored at 85C, as a backup sample.
Genotyping
Genotyping of Weber screening set 9 markers (Yuan
et al. 1997) for 1,450 individuals (777 children from
337 families and 673 of 674 of their parents) was done
by the NHLBI Mammalian Genotyping Service in
Marshfield, WI (Center for Medical Genetics, Marshfield
Medical Research Foundation), by fluorescent-based de-
tection (protocol details can be found at the URL listed
in the Electronic-Database Information section). Average
heterozygosity was .74, and only three markers had
completeness values !90%. For a subset of DNA sam-
ples, we repeated the genotyping, in our lab, with seven
markers (2,838 total samples) and found 99.8% con-
cordance with the genotypes provided to us.
Analytic Methods
Our analytic strategy can be broadly divided into two
classes: primary and secondary analyses. In the primary
analysis, we used the ASPEX package, version 1.12, to
calculate allele-sharing and maximum LOD score (MLS)
values at 3,583 loci (i.e., at all markers and at ∼1-cM
intervals between them), for EDSPs, HCSPs, and LCSPs.
To avoid nonindependence of sib pairs in large sibships,
we chose only the first sib pairs from sibships ofn 1
size n. Furthermore, we assumed that the probability
that sibs share exactly one allele is 50%, thereby re-
ducing the number of free parameters to one (i.e., the
probability that sibs share either zero or, equivalently,
two alleles). We verified that this assumption is reason-
able for a wide range of scenarios, by deriving the ex-
pected allele sharing for an extensive collection of quan-
titative genetic models. We found that, in the
overwhelming majority of cases, sharing of exactly one
allele was close to 50% (authors’ unpublished data).
Moreover, it has been shown, for qualitative traits (Lu-
netta and Rogus 1998), that the simplifying assumption
that 50% share exactly one allele results in a generally
valid test that is typically more powerful than a triangle-
type test (Holmans 1993), even if this assumption is not
strictly satisfied.
Genomewide significance levels were calculated for
the primary analysis by using a resampling technique
developed by Rogus et al. (in press). In this procedure,
the likelihood is approximated by an asymptotically
equivalent expression that can be easily resampled via
successive simulation of independent normal realiza-
tions. In brief, the LOD score assuming that 50% of
cases share exactly one allele can be expressed as W 
, where1 2 2[(St) /(St )] t  (Z  Z )/[(Z  Z )Z j j j 2j 0j 2j 0j 22
, Zij is the probability that the ith pair
1 1(Z  Z )]0j 1j2 2
shares j alleles (conditional on the data) and Z2 is the
overall probability that sib pairs (e.g., EDSPs) share two
alleles. Under the null hypothesis, this is asymptotically
equivalent to , where the Gj are
1∗ 2 2W  [(StG ) /(St )]j j j2
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Table 3
Promising Regions Identified through Primary Analysis
Phenotype and
Sib-Pair Type Marker Nearest Peak Multipoint MLS
Multipoint MLS
(Single-Point MLS)
Multipoint P
(Adjusted)
SBP:
EDSP D11S2019 (GGAA5C04) 2.07 (2.56) .0010 (1.20)
HCSP D17S1303 (GATA64B04) 2.16 (2.35) .0008 (1.20)
LCSP D3S2387 (GATA22G12) (4 cM telomeric to peak) 2.03 (1.61) .0011 (1.20)
LCSP D16S3396 (ATA55A11) 2.74 (1.68) .0002 (.07)
DBP:
LCSP D15S657 (GATA22F01) (9 cM centromeric to peak) 2.69 (2.26) .0002 (.08)
independent and identically distributed from the stan-
dard normal distribution. To find a genomewide critical
value ca across s loci such that P(supW(s)  c ds a
, it is possible to simulate W*(s) repeat-no linkage)  a
edly (merely by simulating new sets of Gj) and to de-
termine ca so that the proportion of replicates with a
W*(s) exceeding ca is a.
Secondary analyses were also performed—first, to val-
idate the results by means of a second software package,
a modified version of MAPMARKER/SIBS, version 4
(Kruglyak and Lander 1995a), and, second, to search
for additional hints of linkage, by varying the statistics
used and the assumptions made. For example, as an
alternative to considering only the first indepen-n 1
dent pairs, we also considered all available pairs, using
MAPMAKER/SIBS (modified) to compensate for non-
independence, by weighting each pair by the factor 2/n
(Suarez and Hodge 1979). (Our extensively tested mod-
ifications to MAPMAKER/SIBS were made to accom-
modate EDSPs, whose sharing will be less than usual,
given linkage. Because we assume that 50% of cases
share exactly one allele, this programming change simply
requires allowing that the sharing of zero alleles be
25%, as opposed to 25%). We also conducted sec-
ondary and diagnostic analyses by using mean tests
(Blackwelder and Elston 1985), unconstrained 2-df tests
(Olson 1997), and single-point (as opposed to multi-
point) tests. Although we did not expect 367 markers
to offer sufficient coverage of the genome to allow for
linkage disequilibrium to be detected with high proba-
bility, we also routinely calculated transmission/dise-
quilibrium test (TDT) statistics, because their determi-
nation in ASPEX is trivial. In the TDT analysis, we
simply searched, via McNemar’s statistic, for frequent
(or infrequent) transmission of alleles to either top-decile
or bottom-decile offspring. For each of our 367 markers,
we identified each allele heterozygous in at least five
parents and compared transmission versus nontrans-
mission from the heterozygous parents (see Schaid
1996). The total number of alleles considered—and,
hence, the number of tests performed—was
2,464–3,122, depending on the type of sib pairs under
consideration. Bonferroni adjustments were made on the
basis of these numbers. Because we used the TDT to test
for linkage—and not to test for association in the pres-
ence of linkage (i.e., fine mapping)—no correction was
needed for multiple offspring within a family (Spielman
et al. 1993). For multipoint linkage analysis, we took
genetic distances from the sex-averaged genetic maps
provided by the Center for Medical Genetics, Marshfield
Medical Research Foundation, and we assessed observed
versus expected recombinations, as well as information
content, by using GENEHUNTER (Kruglyak et al.
1996).
Results
Primary Analysis
Although no chromosomal region was able to achieve
5% genomewide significance, analyses based on either
SBP alone (70 EDSPs, 39 LCSPs, and 185 HCSPs—70,
32, and 159 of them independent, respectively) or DBP
alone (95 EDSPs, 67 LCSPs, and 83 HCSPs—94, 54,
and 73 of them independent, respectively) revealed sev-
eral promising regions (table 3 and fig. 1). For SBP, we
found MLS values of 2.07 atD11S2019 (in EDSPs), 2.16
at D17S1303 (in HCSPs), 2.03 located 4 cM from
D3S2387 (in LCSPs), and 2.74 atD16S3396 (in LCSPs).
For DBP, an MLS of 2.69 was achieved 9 cM from
D15S657 (in LCSPs). However, when we included all
offspring with extreme BP (i.e., all offspring having ei-
ther extreme SBP, extreme DBP, or both), no notable
MLS values were observed. Specifically, we tested 203
independent EDSPs, 80 independent LCSPs, and 215
independent HCSPs, at 3,583 locations across the ge-
nome, but no locus yielded . MLS values wereMLS 1 2.0
based on statistics for the sharing of exactly two alleles
(Risch 1990), as implemented by the ASPEX package.
Although we focused on regions with a primary anal-
ysis where , this was somewhat arbitrary. WeMLS 1 2.0
therefore investigated genomewide significance levels for
the specific multiple correlated tests in our analysis. To
avoid assumptions implicit in general guidelines (Lander
Figure 1 Chromosomes with in the primary analysis. a, Chromosome 11 for SBP in EDSPs. b, Chromosome 17 for SBP in HCSPs.c, Chromosome 3 for SBP in LCSPs. d, ChromosomeMLS 1 2.0
16 for SBP in LCSPs. e, Chromosome 15 for DBP in LCSPs.
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and Kruglyak 1995), we applied a resampling procedure
(Rogus et al., in press) to our data and found that, for
all our scenarios, corresponds to a 5% ge-MLS ≈ 2.9
nomewide false-positive rate. Our largest MLS, 2.74 on
chromosome 16 (SBP in LCSPs) corresponds to a ge-
nomewide P value of .07. Other adjusted P values can
be found in table 3.
Secondary Analysis
Secondary analyses were performed with an alternate
computer program, MAPMAKER/SIBS (Kruglyak and
Lander 1995a) and with other statistics and assump-
tions. Although the change in computer program did
not affect results (99.9% of MLS values matched at the
level of !0.1 unit), some of the statistical modifications
did. For example, the use of mean-sharing statistics
(Blackwelder and Elston 1985) produced a notably
higher MLS, 3.22, for the chromosome 15 region re-
ported above. Otherwise, except for some slightly lower
peaks, the mean-sharing statistics produced MLS profiles
quite similar to those produced by the primary analysis.
We also repeated analyses by using all available (vs. in-
dependent) sib pairs, with appropriate weights (Krug-
lyak and Lander 1995a). Similar MLS profiles resulted,
although peak scores were slightly lower, and three ad-
ditional regions surfaced: near D20S470MLS  1.98
(either SBP or DBP in HCSPs), nearMLS  2.33
D10S1423 (DBP in HCSPs), and nearMLS  2.20
D21S2052 (DBP in LCSPs).
To ensure that our multipoint analysis was not unduly
impacted by genotyping error–induced recombinations,
we next performed single-point analysis. Peak MLS lo-
cations corresponded well (i.e., the difference was !1
marker) with those from multipoint analysis. Two single-
point MLS values did exceed their multipoint counter-
parts (see table 3), and a novel region ( ) atMLS  2.38
D4S3248 emerged for SBP in HCSPs.
In addition to the 1-df (two-allele and mean-sharing)
tests described above, we also performed 2-df tests (Ol-
son 1997) on our data. Albeit larger, owing to an extra
1 df, the 2-df MLS profiles implicate essentially the same
regions: two were somewhat less significant (unadjusted
for both), and two additional regions had 2-dfP. ≈ 006
, roughly equivalent to 1-df :MLS 1 3.0 MLS 1 2.0
(either SBP or DBP in EDSPs) 2 cM fromMLS  3.01
D7S2195 (unadjusted ), andP  .000977 MLS  4.96
(SBP in HCSPs) 5 cM from D20S482 (unadjusted P 
). (We present the unadjusted P values for these.000011
secondary analyses as a way to compare the 2-df results
with the primary, 1-df results.) The latter region, how-
ever, is peculiar because of an excess of sibs sharing one
allele (Olson 1997).
Finally, we calculated a simple TDT statistic for each
marker allele in the screen. Although peak TDT scores
obviously reflect the multitude of statistics considered,
we note that the third highest ( ; BonferroniTDT  17.9
adjusted exact ; top-decile SBP/DBP offspring)P  .086
occurs atD16S3253, one marker from our best primary-
analysis MLS. A weak signal (unadjusted exact P 
[nonsignificant adjusted P value]) was also detected.002
at D7S2195 (bottom-decile SBP), the same locus iden-
tified via 2-df analysis.
Potential Candidate Genes
Recognizing that peak MLS values may not occur at
the precise locus involved in a polygenic disease (Krug-
lyak and Lander 1995b), we identified several candidate
genes in the vicinity of our most promising scores.NOS3
(for nitric oxide synthase 3) and ABP1 (for amiloride-
binding protein-1) map close to the highest MLS on
chromosome 7. AGTRL1 (for angiotensin receptor-like
1) and HUMPCP (PRCP) (for human angiotensinase C
[prolylcarboxypeptidase]) are within reasonable dis-
tances ofD11S2019.Although chromosome 16 contains
many potentially relevant genes, only SLC12A3 (for
thiazide-sensitive Na-Cl cotransporter) is close to
D16S3396.. Both the region homologous to the recently
reported rat susceptibility region (Julier et al. 1997) and
PHA2B (for pseudohypoaldosteronism type II) are the
closest of the candidate genes to D17S1303. ADRA1D
(for alpha-1D-adrenergic receptor) and AVP (for argi-
nine vasopressin) could be candidate genes in proximity
to the highest MLS on chromosome 20. Other candi-
dates include CHRM5 and CHRNA3-5 (for cholinergic
receptors) and TFCOUP2 (for apolipoprotein-regula-
tory protein) on chromosome 15 and ATP2B2 (for ATP-
ase Ca2-transporting plasma membrane) on chromo-
some 3.
One frequently studied candidate gene for BP is that
for angiotensinogen (AGT). Interestingly, when we se-
lected subjects with both high DBP (Jeunemaitre et al.
1992) and hypertensive parents (Watt et al. 1992), anal-
ysis of HCSPs (25 independent sib pairs) revealed a sharp
peak ( ) in close proximity to AGT. TheMLS  2.64
same sample, admittedly small but potentially geneti-
cally enriched, also provides results pointing to a region
of chromosome 12 ( ), a possible hyperten-MLS  2.76
sion-susceptibility QTL (Frossard and Lestringant 1995)
in the vicinity of the PLA2G1B gene.
Discussion
BP regulation is a complex process influenced by nu-
merous genetic and environmental factors. Conse-
quently, there is no cookie-cutter approach for eluci-
dation of the genetic mechanisms involved. We attacked
this problem by scanning the genome for linkage by
using extreme sib pairs. We chose a genome scan because
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previous candidate-gene studies in humans have left
much unexplained about the variation in BP. We chose
linkage analysis because, at the present time, scanning
the genome for association is not feasible. Finally, we
chose to perform our scan on extreme sib pairs in order
to extract maximal information from our genotyping
effort. Our three sib-pair types were analyzed separately
for two reasons. First, because different types of sib pairs
are better for different genetic models, the combining of
sib pairs can result in a masking of an otherwise strong
linkage result. Second, unless reliable knowledge of the
genetics model is available, it is unclear how best to
combine sib pairs. We are, however, in the process of
conducting quantitative analysis that will combine all
data in a single analysis.
Our extreme sib pairs were chosen from a relatively
homogeneous area of China, where BP medication is
uncommon. Furthermore, in all but a single case, pa-
rental DNA was available, thus improving information
content for linkage analysis (Kruglyak and Lander
1995a) and allowing for TDT analysis.
Five promising regions were identified via our primary
analysis, and eight others were identified via secondary
analyses. Because none of the scores reached 5% ge-
nomewide significance, we are now in the process of
genotyping additional extreme sib pairs, as part of an
extension study. In general, these additional families lack
DNA from either one or both parents. However, the
density of the markers in the extension study will com-
pensate for these missing data.
Because our original intuition suggested that we might
see coincident linkages, we did not apply any additional
correction for either multiple sib types or multiple phe-
notype definitions. As discussed above, quantitative
analysis, which utilizes all data simultaneously, could
eliminate this issue to some extent, although it is unclear
whether this is a powerful strategy. If, for example, dif-
ferent genes are involved in SBP versus DBP or in high
BP versus low BP, then pooling of the data may be su-
boptimal. (Also, adjustment for either multiple sib types
or multiple phenotype definitions in this case is not in-
dicated. Thus, we present results for each genome scan
separately, along with the caveat that multiple scans have
been performed.)
In this study, extreme phenotypes were defined as
those within the top and bottom age-adjusted popula-
tion deciles. We chose to use deciles not only because
Risch and Zhang (1995) discussed this approach at great
length but also because we did not foresee an excess of
high-BP (compared with low-BP) subjects, because our
study was population based. Although the cost and com-
plexity of the data collection prevented us from adjusting
our strategy midstream, it would, perhaps, have been
beneficial to relax the lower extreme cutoff, as suggested
by Risch and Zhang (1996). In the extension study, we
are investigating a more refined definition of extreme,
which takes into account additional factors such as sex
and body weight. Moreover, although some previous
studies, particularly those focused on hypertension, have
considered a joint phenotype based on SBP or DBP, our
extension study will treat these two measurements sep-
arately. In this way, we will concentrate on those phe-
notypes that have yielded the best linkage scores and,
simultaneously, will allow for different underlying bio-
logical mechanisms.
In our study, the smallest P value adjusted for multiple
comparisons across any given genome was 0.07. How-
ever, we should point out that we also considered three
types of sib pairs and two BP measurements (although
these scans are clearly not independent). Thus, the ad-
justed P values are even less striking, and the lack of
highly significant MLS values in our study demonstrates
just how difficult an undertaking genomewide searches
for genes influencing complex traits can be. Indeed, even
though (a) EDSPs have been shown to be tremendously
powerful, via theoretical work (Risch and Zhang 1995)
and simulation (Rogus et al. 1997), (b) our population
was homogeneous, and (c) information was collected on
all parents, we were unable to unequivocally locate ge-
nomic regions in this study. Future studies will need to
address this, by collecting larger samples of selected sib
pairs, reducing further any environmental and genetic
heterogeneity, and defining more carefully either the phe-
notype of BP or, perhaps, relevant intermediate pheno-
types. In addition, association studies can be considered
for candidate regions identified on the basis of either
biological function or linkage analysis.
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